71 /100
HIGH RISK
Score updated Jul 14, 2026

BEAT — HeartBeam, Inc. Dilution Risk Tracker

Track BEAT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BEAT — Get alerts when the score changes →

As of July 14, 2026, HeartBeam, Inc. (BEAT) has a DilutionWatch DilutionScore of 71/100, rated HIGH dilution risk. HeartBeam, Inc. has a market capitalization of $48.57M, 55.51M shares outstanding, 38 institutional holders tracked. Key dilution vectors include shelf registration capacity of $100.00M, ATM program capacity of $10.00M, 1.67M outstanding warrants, approximately 2 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌩️
Severe
Multiple high-probability dilution events detected
62%
💰 Capital Raise 93%
• Critical: only 1.7 months cash remaining
• Active shelf registration ($100M, 206% of market cap)
🔄 Reverse Split 45%
• 50-day avg $1.00 approaching $1 threshold
• Only 2 months cash — financial pressure
📉 Score Deterioration 10%
• Score in HIGH risk zone (71/100)
🔔 Track BEAT — Get forecast alerts →

💹 Market Data

Market Cap$48.57M
Shares Outstanding55.51M
Float47.17M
Cash$2.04M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 41.9% shares (2026Q1 vs prior)
38 institutional holders · 6.47M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.40M shares
#2 BlackRock, Inc. 898.3K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 377.2K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.79M
Days to Cover2.9
% of Float3.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
424B5 ATM Apr 16, 2026
8-K 8K EVENT Apr 16, 2026
4 INSIDER TRANSACTION Apr 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BEAT Shareholders

HeartBeam, Inc. (BEAT) has a DilutionScore of 71/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

The most significant dilution vector for BEAT is its shelf registration capacity of $100.0M. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. BEAT has an active ATM (at-the-market) program with $10.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for BEAT in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for BEAT alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding Shelf Registrations → How ATM Offerings Work → Warrants Explained →
Track BEAT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BEAT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BEAT
📊 BEAT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BEAT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.